Pascal and Francis Bibliographic Databases

Help

Search results

Your search

ct.\*:("Pharmaceutical industries")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 755

  • Page / 31
Export

Selection :

  • and

Optimiser la réalisation et l'utilisation des études post-inscription = How to Optimize the Carrying Out and the Development of Post-Registration StudiesBOREL, Thomas; JOUAN-FLAHAULT, Chrystel.Thérapie (Paris). 2011, Vol 66, Num 6, pp 469-472, issn 0040-5957, 4 p.Article

Développement d'une innovation technologique en santé: le cycle CREPS Concept - Recherche - Essais - Produit - Soins : CIC-IT = Development of innovative technologies in health: The CREPS cycle, Concept - Research - Experiment - Product - Safe CareMOREAU-GAUDRY, A; PAZART, L.IRBM. 2010, Vol 31, Num 1, pp 12-21, issn 1959-0318, 10 p.Article

Le brevet: une stratégie pour l'entreprise : CIC-IT = The patent: Strategy for companiesRIPART, A.IRBM. 2010, Vol 31, Num 1, pp 22-25, issn 1959-0318, 4 p.Article

Les centres d'investigation clinique-innovation technologique: des instruments pour les technologies pour la santé : CIC-IT = Technological Innovation and Clinical Investigation Centres: Instruments for Health TechnologiesCOATRIEUX, J.-L; MOREAU-GAUDRY, A; MABO, P et al.IRBM. 2010, Vol 31, Num 1, pp 3-11, issn 1959-0318, 9 p.Article

From East to West: A Japanese Pharma perspective on establishing a global research capabilityTAKATANI, Muneo; KENNY, Barry; HIRD, Nick et al.Drug discovery today. 2009, Vol 14, Num 11-12, pp 611-617, issn 1359-6446, 7 p.Article

Les cyclodextrines et leurs utilisations en pharmacie et cosmétologie = Cyclodextrins ad their use in pharmacy and cosmetologyDUCHENE, D; BACHOT, A; LOFTSSON, T et al.STP pharma pratiques. 2009, Vol 19, Num 1, pp 15-27, issn 1157-1497, 13 p.Article

PICS : un système de coopération en matière d'inspection des produits pharmaceutiques = PICS : A cooperation system in the field of inspection for pharmaceutical productsMORENAS, J.Annales pharmaceutiques françaises. 2009, Vol 67, Num 1, pp 16-19, issn 0003-4509, 4 p.Article

ERREURS DE DISPENSATION DES MÉDICAMENTS DÉTECTÉES DANS LES PILULIERS DESTINÉS AUX PATIENTS HOSPITALISÉS = Medication dispensing errors detected in medication cassettes intended for in-hospital patientsBOHAND, X; CRIPPI, R; LEFEUVRE, L et al.Journal de pharmacie de Belgique. 2008, Vol 63, Num 3, pp 73-77, issn 0047-2166, 5 p.Article

La valeur ajoutée relative : quels outils pour l'évaluer ? = Relative Added Value : What are the Tools to Evalue it?LE JEUNNE, Claire; WORONOFF-LEMSI, Marie-Christine; DAVID, Nadine et al.Thérapie (Paris). 2008, Vol 63, Num 2, issn 0040-5957, 107-117 [10 p.]Article

Dispensing with Conscience : A Legal and Ethical AssessmentWERNOW, Jerome R; GRANT, Donald G.The Annals of pharmacotherapy. 2008, Vol 42, Num 11, pp 1669-1678, issn 1060-0280, 10 p.Article

Comment organiser une politique de choix homogène concernant la réévaluation des médicaments à l'hôpital par la Commission du Médicament et des Dispositifs Médicaux Stériles (COMEDIMS) ? Exemple de la classe des biphosphonates à l'Assistance Publique : Hôpitaux de Paris (AP-HP) = How to manage a homogeneous decision policy for drugs reevaluation from the Pharmacy and Therapeutic Committee? Example of biphosphonates class in the Paris university hospital groupBEDJIDIAN, Sonia; CORDONNIER, Anne-Laure; BROUARD, Agnes et al.Le Pharmacien hospitalier. 2008, Vol 43, Num 175, pp 211-218, issn 0768-9179, 8 p.Article

Enquête de satisfaction d'un pôle médico-technique : bilan et perspectives d'un service de pharmacie = Healthcare practitionner satisfaction assessment regarding pharmaceutical service in anfrench hospital departmentDEMANGE, Claude; NOËL, Simone; VINOT, Nathalie et al.Le Pharmacien hospitalier. 2008, Vol 43, Num 175, pp 227-232, issn 0768-9179, 6 p.Article

Generic Entry, Reformulations and Promotion of SSRIs in the USHUSKAMP, Haiden A; DONOHUE, Julie M; KOSS, Catherine et al.PharmacoEconomics (Auckland). 2008, Vol 26, Num 7, pp 603-616, issn 1170-7690, 14 p.Article

Caracterización de la indicación farmacéutica en farmacias comunitarias de Sevilla capital (España). Estudio piloto = Characterization of counseling for Non-Prescription Drugs at communities pharmacies of Seville (Spain). Pilot StudyFERRER-LOPEZ, I; MACHUCA, M; BAENA, M. I et al.Ars Pharmaceutica. 2007, Vol 48, Num 4, pp 371-385, issn 0004-2927, 15 p.Article

Industrie pharmaceutique: logistique de distributionGOETZ-LOPES, Virginie.Techniques de l'ingénieur. L'Entreprise industrielle. 2007, Vol AGL1, Num AG5435, issn 1282-9072, AG5435.1-AG5435.18Article

Les classes thérapeutiques risquent-elles de tuer l'innovation pharmaceutique ?SOULAS, C.Journal d'économie médicale. 2006, Vol 24, Num 6, pp 307-321, issn 0294-0736, 15 p.Article

Analogpräparate: Marktstrategien der Arzneimittelhersteller wie der Arzneimitteleinkäufer am Beispiel nichtionischer (monomerer) Röntgenkontrastmittel = Me-too pharmaceuticals: Marketing-strategies of drugproducers and drug purchasers. Example: Non-ionic contrast mediaWILD, C; S.PUIG.Das Gesundheitswesen (Stuttgart. Thieme). 2004, Vol 66, Num 11, pp 716-722, issn 0941-3790, 7 p.Article

Initiatives to control drug costs associated with an independent physician associationABOURJAILY, Paul; KROSS, Joan; GOUVEIA, William A et al.American journal of health-system pharmacy. 2003, Vol 60, Num 3, pp 269-272, issn 1079-2082, 4 p.Article

European healthcare policies for controlling drug expenditureESS, Silvia M; SCHNEEWEISS, Sebastian; SZUCS, Thomas D et al.PharmacoEconomics (Auckland). 2003, Vol 21, Num 2, pp 89-103, issn 1170-7690, 15 p.Article

Advanced science education in the regulatory arena: The Center for Drug Evaluation and Research Experience at the Food and Drug AdministrationAJAYI, Funmilayo O; WILCOX, Dale F; UHL, Kathleen et al.Journal of clinical pharmacology. 2002, Vol 42, Num 7, pp 711-717, issn 0091-2700Article

Pharmaceutical manufacturer assistance programsCHISHOLM, Marie A; DIPIRO, Joseph T.Archives of internal medicine (1960). 2002, Vol 162, Num 7, pp 780-784, issn 0003-9926Article

Pharmaceutical sales representatives and the doctor/patient relationshipWALL, L. Lewis; BROWN, Douglas.Obstetrics and gynecology (New York. 1953). 2002, Vol 100, Num 3, pp 594-599, issn 0029-7844Article

The contribution of cohort studies to prescribing researchSIMPSON, J. A; HANNAFORD, P. C.Journal of clinical pharmacy and therapeutics (Print). 2002, Vol 27, Num 2, pp 151-156, issn 0269-4727Article

The product label: How pharmacokinetics and pharmacodynamics reach the prescriberMARROUM, Patrick J; GOBBURU, Jogarao.Clinical pharmacokinetics. 2002, Vol 41, Num 3, pp 161-169, issn 0312-5963Article

Accountability of the pharmaceutical industryDUKES, M. N.Lancet (British edition). 2002, Vol 360, Num 9346, pp 1682-1684, issn 0140-6736, 3 p.Article

  • Page / 31